The FDA has expanded indications for methylphenidate (Concerta) extended-release tablets to include adults aged 18 to 65 with ADHD.
For more information visit:
FDA
Sponsored by The Doctor’s Channel
The FDA has expanded indications for methylphenidate (Concerta) extended-release tablets to include adults aged 18 to 65 with ADHD.
For more information visit:
FDA
Sponsored by The Doctor’s Channel